Results 91 to 100 of about 4,323 (166)
Síndrome de Lambert-Eaton paraneoplásico en carcinoma de células pequeñas de pulmón
Lambert Eaton myasthenic syndrome is a paraneoplastic autoimmune pathology mostly associated with lung cancer, which manifests itself with involvement of the neuromuscular junction and autonomic dysfunctions.
González Houdelath, Karolina +4 more
core +1 more source
Treatment for Lambert-Eaton myasthenic syndrome
Background Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmission Objectives The objective was to ...
Maddison P, Sedehizadeh S, Keogh M
core
International audienceLambert-Eaton myasthenic syndrome is an autoimmune disease that impairs neuromuscular transmission. Several studies suggest that neurotransmitter release is reduced by an immune response directed against the calcium channel complex ...
Raymond, Cécile +5 more
core
Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Lambert-Eaton myasthenic syndrome (LEMS) is a neuromuscular autoimmune disease that has served as a model for autoimmunity and tumour immunology. In LEMS, the characteristic muscle weakness is thought to be caused by pathogenic autoantibodies directed ...
Lang, B. +9 more
core +1 more source
CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy
Background Chimeric antigen receptor (CAR) T cell therapy is emerging as a promising approach for B cell-driven neurological autoimmune disorders, particularly those characterized by pathogenic autoantibodies that target key neural structures.
Muzi Wen +10 more
doaj +1 more source
Decoding Multiple Antibody Positivity: Lessons from Paraneoplastic Sensory Ataxia
Paraneoplastic neurologic syndromes are cancer-associated, immune-mediated neurologic manifestations that may involve any part of the nervous system.
S Sidharth +8 more
doaj +1 more source
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
AIM: To assess the treatment effects of rituximab in a population of patients with myasthenia gravis and Lambert-Eaton myasthenic syndrome. METHODS: Data on all treated patients in the UK were collected from referring physicians, with full case ...
Hilton-Jones, David +17 more
core +1 more source
Highlight: • LEMS is a rare neurological disease with fluctuating symptoms • Delays and misdiagnosis of LEMS disease often occur • The two main pathophysiologies of LEMS are autoimmune and paraneoplastic.
Ichlasul Mahdi Fardhani +2 more
doaj +1 more source
International audienceLarge granular lymphocytic (LGL) leukemia is an uncommon clonal lymphoproliferative disorder. Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare neuromuscular autoimmune disease caused by pathogenic autoantibodies targeting the ...
Roche, Corinne +6 more
core +1 more source
Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management.
Lambert-Eaton myasthenic syndrome (LEMS) is a pre-synaptic disorder of the neuromuscular and autonomic transmission mediated by antibodies to voltage-gated calcium channels at the motor nerve terminal.
Giometto B +20 more
core +1 more source

